MENU
PJP
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PJP stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health
PJP
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PJP with price predictions
Jun 12, 2026

Momentum Indicator for PJP turns positive, indicating new upward trend

PJP saw its Momentum Indicator move above the 0 level on May 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PJP just turned positive on June 05, 2026. Looking at past instances where PJP's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 254 cases where PJP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PJP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PJP broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF ETF is 108.43B. The market cap for tickers in the group ranges from 737.75M to 1.01T. LLY holds the highest valuation in this group at 1.01T. The lowest valued company is GERN at 737.75M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 3%. For the same ETF, the average monthly price growth was 5%, and the average quarterly price growth was 8%. AMRX experienced the highest price growth at 18%, while REGN experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF ETF was -14%. For the same stocks of the ETF, the average monthly volume growth was -19% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 49
Price Growth Rating: 46
SMR Rating: 60
Profit Risk Rating: 57
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
PJP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com
Momentum Indicator for PJP turns positive, indicating new upward trend